Comparative analysis of specificity and sensitivity between Cobas 6800 system and SARS-CoV-2 rRT-PCR to detect COVID-19 infection in clinical samplesCobas 6800 시스템과 SARS-CoV-2 rRT-PCR 간의 특이도 및 민감도를 비교 분석하여 임상 시료에서 COVID-19 감염 감지Article Published on 2022-07-192022-09-11 Journal: Archives of Microbiology [Category] [DOI] 10.1007/s00203-022-03118-y PMC 바로가기 [Article Type] Article
Tixagevimab + Cilgavimab: First ApprovalTixagevimab + Cilgavimab: 첫 번째 승인Review Published on 2022-06-012022-09-12 Journal: Drugs [Category] [DOI] 10.1007/s40265-022-01731-1 PMC 바로가기 [Article Type] Review
Opportunities and counterintuitive challenges for decentralized clinical trials to broaden participant inclusion Reviews Published on 2022-05-052022-10-05 Journal: NPJ Digital Medicine [Category] [DOI] 10.1038/s41746-022-00603-y [Article Type] Reviews
Inhaled remdesivir reduces viral burden in a nonhuman primate model of SARS-CoV-2 infection흡입형 렘데시비르는 SARS-CoV-2 감염의 비인간 영장류 모델에서 바이러스 부담을 줄입니다Article Published on 2022-02-232022-09-11 Journal: Science Translational Medicine [Category] [DOI] 10.1126/scitranslmed.abl8282 PMC 바로가기 [Article Type] Article
Diltiazem inhibits SARS-CoV-2 cell attachment and internalization and decreases the viral infection in mouse lungDiltiazem은 SARS-CoV-2 세포 부착 및 내재화를 억제하고 마우스 폐의 바이러스 감염을 감소시킵니다Research Article Published on 2022-02-172022-09-10 Journal: PLoS Pathogens [Category] [DOI] 10.1371/journal.ppat.1010343 PMC 바로가기 [Article Type] Research Article
Pharmacokinetic/Pharmacodynamic Considerations of Alternate Dosing Strategies of Tocilizumab in COVID-19COVID-19에서 토실리주맙의 대체 투여 전략의 약동학/약력학적 고려사항Review Published on 2022-02-012022-09-12 Journal: Clinical pharmacokinetics [Category] [DOI] 10.1007/s40262-021-01092-0 PMC 바로가기 [Article Type] Review
Anticipated pharmacological role of Aviptadil on COVID-19Review Published on 2022-02-012022-10-04 Journal: Environmental science and pollution research inter [Category] [DOI] 10.1007/s11356-021-17824-5 PMC 바로가기 [Article Type] Review
Remdesivir Use in the Setting of Severe Renal Impairment: A Theoretical Concern or Real Risk?심각한 신장 장애 상황에서 렘데시비르 사용: 이론적 우려 또는 실제 위험?Article Published on 2021-12-062022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] [DOI] 10.1093/cid/ciaa1851 PMC 바로가기 [Article Type] Article
Factors associated with fatal coronavirus disease 2019 infections among cancer patients in the US FDA Adverse Event Reporting System databaseResearch Article Published on 2021-11-022022-10-31 Journal: Future Oncology [Category] [DOI] 10.2217/fon-2021-0816 PMC 바로가기 [Article Type] Research Article
Remdesivir: Quo vadis?렘데시비르: 쿼바디스?Review Published on 2021-11-012022-09-11 Journal: Biochemical pharmacology [Category] [DOI] 10.1016/j.bcp.2021.114800 PMC 바로가기 [Article Type] Review